Literature DB >> 33465461

Anticancer and anti-inflammatory properties of mangiferin: A review of its molecular mechanisms.

Suhuan Mei1, Haile Ma2, Xiumin Chen3.   

Abstract

Chronic inflammation is crucial for the pathological process of tumors due to increasing the infiltration of cytokines, growth factors, and chemokines to the tumor microenvironment. Phenolic compounds are considered natural remedies for inflammation and cancer. Mangiferin is a C-glycosyl xanthone that possesses numerous pharmacological activities. It has the potential to attenuate inflammation in different organs through the mechanisms of inhibiting pattern recognition receptors, regulating cell signaling pathways, activating autophagy, inhibiting the secretion of inflammatory mediators, and protecting intestinal barrier integrity, which in turn prevents cancer. In this review, the recent advances in the anti-inflammation and anti-cancer mechanisms of mangiferin as well as its safety and toxicity were summarized. The impacts of modified mangiferin and the synergic effects with other components were also discussed. Understanding the molecular targets of mangiferin is of great significance for its better application in the amelioration of inflammation-related diseases.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Inflammation; Intestinal barrier; Mangiferin; Molecular mechanism; Toxicity

Mesh:

Substances:

Year:  2021        PMID: 33465461     DOI: 10.1016/j.fct.2021.111997

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Irigenin, a novel lead from Iris confusa for management of Helicobacter pylori infection with selective COX-2 and HpIMPDH inhibitory potential.

Authors:  Passent M Abdel-Baki; Moshera M El-Sherei; Amal E Khaleel; Marwa M Abdel-Aziz; Mona M Okba
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

2.  Zinc oxide nanoparticles synthesized using coffee leaf extract assisted with ultrasound as nanocarriers for mangiferin.

Authors:  Qiang Wang; Suhuan Mei; Perumal Manivel; Haile Ma; Xiumin Chen
Journal:  Curr Res Food Sci       Date:  2022-05-18

Review 3.  Topical gel-based biomaterials for the treatment of diabetic foot ulcers.

Authors:  James R Bardill; Melissa R Laughter; Michael Stager; Kenneth W Liechty; Melissa D Krebs; Carlos Zgheib
Journal:  Acta Biomater       Date:  2021-10-30       Impact factor: 8.947

Review 4.  Therapeutic potential of mangiferin against kidney disorders and its mechanism of action: A review.

Authors:  Pei Teng Lum; Mahendran Sekar; Siew Hua Gan; Srikanth Jeyabalan; Srinivasa Reddy Bonam; Nur Najihah Izzati Mat Rani; Ku-Marina Ku-Mahdzir; Lay Jing Seow; Yuan Seng Wu; Vetriselvan Subramaniyan; Neeraj Kumar Fuloria; Shivkanya Fuloria
Journal:  Saudi J Biol Sci       Date:  2021-11-16       Impact factor: 4.219

5.  Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson's Disease in Rats.

Authors:  Prafulla Chandra Tiwari; Manju J Chaudhary; Rishi Pal; Shipra Kartik; Rajendra Nath
Journal:  Ann Neurosci       Date:  2021-11-02

6.  Chemical and Biological Evidence of the Efficacy of Shengxian Decoction for Treating Human Lung Adenocarcinoma.

Authors:  Kejuan Li; Fengming You; Qin Zhang; Ruijiao Yuan; Qianghua Yuan; Xi Fu; Yifeng Ren; Qian Wang; Xiaohong Li; Zhenya Zhang; Mototada Shichiri; Yue Yu
Journal:  Front Oncol       Date:  2022-03-18       Impact factor: 6.244

7.  Reno-protective effect of mangiferin against methotrexate-induced kidney damage in male rats: PPARγ-mediated antioxidant activity.

Authors:  Seba Hassan Attia; Shimaa Mustafa Elshazly; Mahmoud Mohamed Abdelaal; Eman Soliman
Journal:  Saudi Pharm J       Date:  2022-07-01       Impact factor: 4.562

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.